US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Telomir Pharmaceuticals

1.17

+0.04003.54%

Post-market: 1.170.00000.00%16:04 EDT

Volume:56.35K

Turnover:65.93K

Market Cap:80.47M

PE:-1.28

High:1.20

Open:1.13

Low:1.13

Close:1.13

52wk High:2.09

52wk Low:0.8885

Shares:68.78M

Float Shares:47.51M

Volume Ratio:1.10

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9106

EPS(LYR):-0.3300

ROE:-213.10%

ROA:-122.81%

PB:15.99

PE(LYR):-3.55

Loading ...

Overview Company News Filings

Telomir Net Loss Narrows to $1.72 Million in Q2 FY26; Revenue Flat at no Revenue

Telomir Plans Phase 1/2 Trial of Telomir-Zn in Triple-Negative Breast Cancer After Preclinical Publication

Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models

Telomir Pharmaceuticals Announces Annual Shareholder Meeting Via Virtual Webcast

Telomir Pharmaceuticals announces publication of data on Telomir-Zn

Telomir Pharmaceuticals reports Telomir-Zn restores insulin sensitivity in preclinical type 2 diabetes model study

Telomir Names Andriy Mushak as Fractional Chief Financial Officer

MT Newswires Live

Telomir Pharmaceuticals - Alan Weichselbaum to Step Down as CFO Effective June 6, 2026 - SEC Filing

THOMSON REUTERS

Telomir Pharmaceuticals - Appoints Andriy Mushak as Fractional CFO Effective June 6, 2026 - SEC Filing

THOMSON REUTERS

Telomir Pharmaceuticals names Andriy Mushak fractional CFO, replacing Alan Weichselbaum

Telomir Pharmaceuticals reports peer-reviewed publication of data on Telomir-Zn

Telomir says preclinical Telomir-Zn study shows dose-dependent survival gain in Wilson’s disease model

Telomir net loss narrows to $990,947 in Q1 2026

Telomir announces U.S. FDA cleared IND application for Telomir-Zn

Telomir Pharmaceuticals Inc - Plans to Initiate Phase 1/2 Trial for Telomir-Zn in 1H 2026 - SEC Filing

THOMSON REUTERS

Telomir Pharmaceuticals wins FDA IND clearance for Telomir-Zn in triple-negative breast cancer

Telomir Pharmaceuticals Completes TELI Acquisition, Expands Telomir-1 Rights

Telomir issues 34,389,710 unregistered shares in TELI acquisition

Telomir Pharmaceuticals Regains Nasdaq Listing Rule Compliance

Telomir submits FDA IND for Telomir-1 in advanced triple-negative breast cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/TELO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TELO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TELO\",,,,,undefined,":{"symbol":"TELO","market":"US","secType":"STK","nameCN":"Telomir Pharmaceuticals","latestPrice":1.17,"timestamp":1787601600000,"preClose":1.13,"halted":0,"volume":56353,"hourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.17,"latestTime":"16:04 EDT","volume":4,"amount":4.68,"timestamp":1787601844253,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03539823008849561,"floatShares":47511600,"shares":68775000,"eps":-0.9106,"marketStatus":"Post-Mkt","change":0.04,"latestTime":"08-24 16:04:08 EDT","open":1.13,"high":1.2,"low":1.13,"amount":65928.3383363,"amplitude":0.061947,"askPrice":1.18,"askSize":100,"bidPrice":1.09,"bidSize":214,"shortable":3,"etf":0,"ttmEps":-0.9106,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":1.13,"preHourTrading":{"tag":"盘前","latestPrice":1.11,"preClose":1.13,"latestTime":"07:00 EDT","volume":2,"amount":2.22,"timestamp":1787569211763,"change":-0.02,"changeRate":-0.017699,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.17,"latestTime":"16:04 EDT","volume":4,"amount":4.68,"timestamp":1787601844253,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.098889},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TELO\",,,,,undefined,":{"symbol":"TELO","floatShares":47511600,"roa":"-122.81%","roe":"-213.10%","lyrEps":-0.329999,"volumeRatio":1.098889,"shares":68775000,"dividePrice":0,"high":1.2,"amplitude":0.061947,"preClose":1.13,"low":1.13,"week52Low":0.88845,"pbRate":"15.99","week52High":2.091,"institutionHeld":0,"latestPrice":1.17,"committee":0.363057,"eps":-0.9106,"divideRate":0,"volume":56353,"delay":0,"ttmEps":-0.9106,"open":1.13,"prevYearClose":1.33,"prevWeekClose":1.13,"prevMonthClose":1.21,"prevQuarterClose":1.28,"fiveDayClose":1.06,"twentyDayClose":1.23,"sixtyDayClose":1.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TELO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"TELO","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.79},{"market":"US","date":"2026-05-14","symbol":"TELO","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"","actualEps":-0.03},{"market":"US","date":"2026-03-17","symbol":"TELO","fiscalQuarterEnding":"2025/12","expectedEps":-0.07,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773720000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-11-10","symbol":"TELO","fiscalQuarterEnding":"2025/09","expectedEps":-0.07,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2025-08-14","symbol":"TELO","fiscalQuarterEnding":"2025/06","expectedEps":-0.08,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TELO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TELO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TELO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TELO","date":"2026-08-21","current":-1.24094,"percent":0.093354,"low":-83.265127,"twenty":-8.846984,"median":-5.470931,"eighty":-4.064456,"high":-2.36905,"avg":-8.719869,"sd":11.203413,"marketCap":77715700},"quantilePoints":[{"date":"2024-02-16","current":-56.39638,"twenty":-61.770129,"median":-49.049457,"eighty":-41.982417,"marketCap":238655100},{"date":"2024-02-23","current":-62.343889,"twenty":-63.029602,"median":-60.594622,"eighty":-46.922348,"marketCap":263823442},{"date":"2024-03-01","current":-63.46342,"twenty":-63.421438,"median":-62.588787,"eighty":-53.457611,"marketCap":268561012},{"date":"2024-03-08","current":-60.874505,"twenty":-63.351467,"median":-62.553802,"eighty":-58.915325,"marketCap":257605381},{"date":"2024-03-15","current":-45.550923,"twenty":-63.197532,"median":-61.749139,"eighty":-48.657621,"marketCap":192759889},{"date":"2024-03-22","current":-47.510102,"twenty":-63.029602,"median":-60.594622,"eighty":-45.928765,"marketCap":201050637},{"date":"2024-03-28","current":-35.580099,"twenty":-62.973626,"median":-56.39638,"eighty":-42.472212,"marketCap":150565904},{"date":"2024-04-05","current":-16.558518,"twenty":-62.833684,"median":-48.559663,"eighty":-36.881554,"marketCap":216450701},{"date":"2024-04-12","current":-18.574281,"twenty":-62.595784,"median":-46.390571,"eighty":-17.881143,"marketCap":242800474},{"date":"2024-04-19","current":-18.007992,"twenty":-62.469837,"median":-45.480952,"eighty":-18.234508,"marketCap":235398021},{"date":"2024-04-26","current":-15.402836,"twenty":-62.287913,"median":-41.632564,"eighty":-16.272973,"marketCap":201343774},{"date":"2024-05-03","current":-15.493668,"twenty":-61.8401,"median":-38.868721,"eighty":-15.530047,"marketCap":202531127},{"date":"2024-05-10","current":-14.814122,"twenty":-61.126399,"median":-34.985348,"eighty":-15.280653,"marketCap":193648183},{"date":"2024-05-17","current":-9.713938,"twenty":-60.762552,"median":-20.205194,"eighty":-14.460757,"marketCap":183044909},{"date":"2024-05-24","current":-9.899514,"twenty":-60.034856,"median":-18.959358,"eighty":-13.282876,"marketCap":186541828},{"date":"2024-05-31","current":-9.506677,"twenty":-58.635442,"median":-18.087272,"eighty":-12.474215,"marketCap":179139374},{"date":"2024-06-07","current":-8.846709,"twenty":-55.220872,"median":-16.988785,"eighty":-10.175947,"marketCap":166703252},{"date":"2024-06-14","current":-8.642433,"twenty":-50.224965,"median":-16.082609,"eighty":-9.764378,"marketCap":162853977},{"date":"2024-06-21","current":-8.249595,"twenty":-49.049457,"median":-15.652229,"eighty":-9.506677,"marketCap":155451523},{"date":"2024-06-28","current":-7.558201,"twenty":-48.069868,"median":-15.505107,"eighty":-8.846709,"marketCap":142423205},{"date":"2024-07-05","current":-6.803952,"twenty":-47.622055,"median":-15.431264,"eighty":-8.793283,"marketCap":128210494},{"date":"2024-07-12","current":-6.489682,"twenty":-46.614477,"median":-14.995334,"eighty":-8.611006,"marketCap":122288531},{"date":"2024-07-19","current":-5.892568,"twenty":-46.222641,"median":-14.134574,"eighty":-8.227596,"marketCap":111036802},{"date":"2024-07-26","current":-6.096844,"twenty":-45.67687,"median":-13.432376,"eighty":-7.822188,"marketCap":114886078},{"date":"2024-08-02","current":-5.248314,"twenty":-45.438969,"median":-12.639572,"eighty":-6.797667,"marketCap":98896778},{"date":"2024-08-09","current":-6.741098,"twenty":-44.067543,"median":-12.367753,"eighty":-6.690814,"marketCap":127026102},{"date":"2024-08-16","current":-6.303607,"twenty":-42.052388,"median":-10.284417,"eighty":-6.64996,"marketCap":118143157},{"date":"2024-08-23","current":-8.29422,"twenty":-40.401079,"median":-9.899514,"eighty":-6.678244,"marketCap":155451523},{"date":"2024-08-30","current":-8.278421,"twenty":-39.141606,"median":-9.736016,"eighty":-6.690814,"marketCap":155155425},{"date":"2024-09-06","current":-8.136234,"twenty":-38.861724,"median":-9.674022,"eighty":-6.712813,"marketCap":152490542},{"date":"2024-09-13","current":-9.589698,"twenty":-36.881554,"median":-9.506677,"eighty":-6.734812,"marketCap":179731570},{"date":"2024-09-20","current":-12.386034,"twenty":-35.223248,"median":-9.49882,"eighty":-6.759954,"marketCap":232140941},{"date":"2024-09-27","current":-10.774586,"twenty":-34.271647,"median":-9.637093,"eighty":-6.791381,"marketCap":201938931},{"date":"2024-10-04","current":-8.578593,"twenty":-25.750182,"median":-9.548188,"eighty":-6.888805,"marketCap":160781290},{"date":"2024-10-11","current":-8.009846,"twenty":-20.168951,"median":-9.479108,"eighty":-7.001943,"marketCap":150121756},{"date":"2024-10-18","current":-7.425301,"twenty":-19.534707,"median":-9.44751,"eighty":-7.071981,"marketCap":139166125},{"date":"2024-10-25","current":-7.01454,"twenty":-19.059025,"median":-9.384317,"eighty":-6.903527,"marketCap":131467574},{"date":"2024-11-01","current":-6.714368,"twenty":-18.728312,"median":-9.226332,"eighty":-6.834437,"marketCap":125841709},{"date":"2024-11-08","current":-6.666973,"twenty":-18.282076,"median":-8.941959,"eighty":-6.759954,"marketCap":124953415},{"date":"2024-11-15","current":-4.809979,"twenty":-18.039704,"median":-8.846709,"eighty":-6.708049,"marketCap":110444606},{"date":"2024-11-22","current":-5.467643,"twenty":-17.654627,"median":-8.799568,"eighty":-6.673736,"marketCap":125545611},{"date":"2024-11-29","current":-5.132363,"twenty":-17.074838,"median":-8.768141,"eighty":-6.632216,"marketCap":117847059},{"date":"2024-12-06","current":-8.407791,"twenty":-16.522185,"median":-8.642433,"eighty":-6.569924,"marketCap":193055987},{"date":"2024-12-13","current":-6.737953,"twenty":-16.313655,"median":-8.594391,"eighty":-6.600602,"marketCap":154713889},{"date":"2024-12-20","current":-6.712037,"twenty":-15.964821,"median":-8.461728,"eighty":-6.495967,"marketCap":154118835},{"date":"2024-12-27","current":-6.310352,"twenty":-15.760957,"median":-8.366804,"eighty":-6.403683,"marketCap":144895507},{"date":"2025-01-03","current":-5.856836,"twenty":-15.652229,"median":-8.303377,"eighty":-6.363974,"marketCap":134482072},{"date":"2025-01-10","current":-5.325574,"twenty":-15.570683,"median":-8.28632,"eighty":-6.315537,"marketCap":122283477},{"date":"2025-01-17","current":-6.077115,"twenty":-15.523297,"median":-8.249595,"eighty":-6.288654,"marketCap":139540026},{"date":"2025-01-24","current":-6.517673,"twenty":-15.50282,"median":-8.139601,"eighty":-6.28436,"marketCap":149655935},{"date":"2025-01-31","current":-6.297394,"twenty":-15.473282,"median":-8.073041,"eighty":-6.236001,"marketCap":144597981},{"date":"2025-02-07","current":-7.867,"twenty":-15.425578,"median":-8.088839,"eighty":-6.236001,"marketCap":130062872},{"date":"2025-02-14","current":-7.722981,"twenty":-15.280653,"median":-8.030693,"eighty":-6.247693,"marketCap":127681858},{"date":"2025-02-21","current":-7.038894,"twenty":-15.117652,"median":-7.97035,"eighty":-6.260979,"marketCap":116372043},{"date":"2025-02-28","current":-7.200915,"twenty":-14.922849,"median":-7.899257,"eighty":-6.280067,"marketCap":119050684},{"date":"2025-03-07","current":-7.830995,"twenty":-14.578546,"median":-7.867,"eighty":-6.294726,"marketCap":129467618},{"date":"2025-03-14","current":-8.245048,"twenty":-14.152696,"median":-7.888185,"eighty":-6.298884,"marketCap":136313033},{"date":"2025-03-21","current":-8.209043,"twenty":-13.908059,"median":-7.867,"eighty":-6.302115,"marketCap":135717779},{"date":"2025-03-28","current":-7.110904,"twenty":-13.595467,"median":-7.836063,"eighty":-6.306305,"marketCap":117562550},{"date":"2025-04-04","current":-5.27467,"twenty":-13.332709,"median":-7.821994,"eighty":-6.280067,"marketCap":87204626},{"date":"2025-04-11","current":-4.842615,"twenty":-12.988406,"median":-7.793903,"eighty":-6.226574,"marketCap":80061584},{"date":"2025-04-17","current":-4.464567,"twenty":-12.673549,"median":-7.741272,"eighty":-6.154861,"marketCap":73811424},{"date":"2025-04-25","current":-4.590583,"twenty":-12.555761,"median":-7.674628,"eighty":-6.056383,"marketCap":75894811},{"date":"2025-05-02","current":-4.662592,"twenty":-12.434833,"median":-7.63297,"eighty":-6.012327,"marketCap":77085317},{"date":"2025-05-09","current":-4.48257,"twenty":-12.382378,"median":-7.614926,"eighty":-5.935607,"marketCap":74109050},{"date":"2025-05-16","current":-5.972632,"twenty":-12.227313,"median":-7.558201,"eighty":-5.893196,"marketCap":74406677},{"date":"2025-05-23","current":-5.255916,"twenty":-11.632708,"median":-7.513523,"eighty":-5.862019,"marketCap":65477876},{"date":"2025-05-30","current":-5.017011,"twenty":-11.501318,"median":-7.475136,"eighty":-5.83092,"marketCap":62501609},{"date":"2025-06-06","current":-4.801996,"twenty":-11.15375,"median":-7.4411,"eighty":-5.738446,"marketCap":59822968},{"date":"2025-06-13","current":-4.778106,"twenty":-10.774586,"median":-7.421122,"eighty":-5.634716,"marketCap":59525342},{"date":"2025-06-20","current":-4.204733,"twenty":-10.62292,"median":-7.416943,"eighty":-5.48096,"marketCap":52382300},{"date":"2025-06-27","current":-4.06139,"twenty":-10.489162,"median":-7.344933,"eighty":-5.438999,"marketCap":50596540},{"date":"2025-07-03","current":-2.747411,"twenty":-10.309584,"median":-7.267316,"eighty":-5.403258,"marketCap":34227071},{"date":"2025-07-11","current":-2.795192,"twenty":-10.167924,"median":-7.19827,"eighty":-5.305212,"marketCap":34822325},{"date":"2025-07-18","current":-2.890754,"twenty":-10.119238,"median":-7.110904,"eighty":-5.252875,"marketCap":36012831},{"date":"2025-07-25","current":-5.470931,"twenty":-9.985876,"median":-7.051517,"eighty":-5.230053,"marketCap":68156516},{"date":"2025-08-01","current":-4.632645,"twenty":-9.902657,"median":-7.038894,"eighty":-5.134824,"marketCap":57713194},{"date":"2025-08-08","current":-4.137175,"twenty":-9.874769,"median":-6.990842,"eighty":-5.099417,"marketCap":51540660},{"date":"2025-08-15","current":-3.88944,"twenty":-9.817021,"median":-6.919749,"eighty":-5.017011,"marketCap":48454393},{"date":"2025-08-22","current":-3.011505,"twenty":-9.770664,"median":-6.814455,"eighty":-5.00486,"marketCap":48421455},{"date":"2025-08-29","current":-2.971351,"twenty":-9.7316,"median":-6.741098,"eighty":-4.932627,"marketCap":47775835},{"date":"2025-09-05","current":-2.489511,"twenty":-9.712744,"median":-6.725384,"eighty":-4.883224,"marketCap":40028402},{"date":"2025-09-12","current":-2.750508,"twenty":-9.681408,"median":-6.705303,"eighty":-4.805189,"marketCap":44224928},{"date":"2025-09-19","current":-2.810738,"twenty":-9.618135,"median":-6.678244,"eighty":-4.746437,"marketCap":45193358},{"date":"2025-09-26","current":-2.945698,"twenty":-9.55649,"median":-6.666973,"eighty":-4.681375,"marketCap":47363358},{"date":"2025-10-03","current":-2.924657,"twenty":-9.500391,"median":-6.651174,"eighty":-4.637423,"marketCap":47025048},{"date":"2025-10-10","current":-4.060855,"twenty":-9.486221,"median":-6.601898,"eighty":-4.590583,"marketCap":65293772},{"date":"2025-10-17","current":-3.408593,"twenty":-9.479108,"median":-6.517673,"eighty":-4.556077,"marketCap":54806171},{"date":"2025-10-24","current":-3.114023,"twenty":-9.472788,"median":-6.471284,"eighty":-4.524565,"marketCap":50069835},{"date":"2025-10-31","current":-3.156105,"twenty":-9.45067,"median":-6.414196,"eighty":-4.48257,"marketCap":50746455},{"date":"2025-11-07","current":-2.840494,"twenty":-9.412754,"median":-6.396899,"eighty":-4.45201,"marketCap":45671809},{"date":"2025-11-14","current":-3.909223,"twenty":-9.384317,"median":-6.363974,"eighty":-4.258858,"marketCap":43980261},{"date":"2025-11-21","current":-4.247815,"twenty":-9.364121,"median":-6.343714,"eighty":-4.249695,"marketCap":47789549},{"date":"2025-11-28","current":-4.095016,"twenty":-9.331287,"median":-6.313593,"eighty":-4.204733,"marketCap":46070501},{"date":"2025-12-05","current":-4.156135,"twenty":-9.283207,"median":-6.30112,"eighty":-4.101128,"marketCap":46758120},{"date":"2025-12-12","current":-4.522853,"twenty":-9.116263,"median":-6.282214,"eighty":-4.127895,"marketCap":50883837},{"date":"2025-12-19","current":-4.186695,"twenty":-9.035462,"median":-6.238265,"eighty":-4.127895,"marketCap":47101930},{"date":"2025-12-26","current":-4.339494,"twenty":-8.956704,"median":-6.222552,"eighty":-4.137175,"marketCap":48820978},{"date":"2026-01-02","current":-4.064456,"twenty":-8.944908,"median":-6.154861,"eighty":-4.119463,"marketCap":45726691},{"date":"2026-01-09","current":-4.339494,"twenty":-8.902896,"median":-6.1047,"eighty":-4.119463,"marketCap":48820978},{"date":"2026-01-16","current":-4.186695,"twenty":-8.85636,"median":-6.068194,"eighty":-4.119463,"marketCap":47101930},{"date":"2026-01-23","current":-4.095016,"twenty":-8.846892,"median":-6.038242,"eighty":-4.095016,"marketCap":46070501},{"date":"2026-01-30","current":-3.728298,"twenty":-8.846709,"median":-6.012327,"eighty":-4.082792,"marketCap":41944784},{"date":"2026-02-06","current":-3.422699,"twenty":-8.828026,"median":-5.986849,"eighty":-4.06323,"marketCap":38506687},{"date":"2026-02-13","current":-3.30046,"twenty":-8.805969,"median":-5.937145,"eighty":-4.036058,"marketCap":37131448},{"date":"2026-02-20","current":-3.453259,"twenty":-8.799568,"median":-5.894139,"eighty":-4.033896,"marketCap":38850497},{"date":"2026-02-27","current":-4.003336,"twenty":-8.786997,"median":-5.882751,"eighty":-3.950834,"marketCap":45039072},{"date":"2026-03-06","current":-3.972776,"twenty":-8.724143,"median":-5.850357,"eighty":-3.942216,"marketCap":44695262},{"date":"2026-03-13","current":-4.278374,"twenty":-8.651861,"median":-5.814739,"eighty":-3.942216,"marketCap":48133359},{"date":"2026-03-20","current":-4.358205,"twenty":-8.642433,"median":-5.751341,"eighty":-3.950834,"marketCap":45382881},{"date":"2026-03-27","current":-4.160105,"twenty":-8.635855,"median":-5.672579,"eighty":-3.967366,"marketCap":43320023},{"date":"2026-04-02","current":-4.358205,"twenty":-8.619669,"median":-5.634716,"eighty":-3.965563,"marketCap":45382881},{"date":"2026-04-10","current":-4.160105,"twenty":-8.591231,"median":-5.500145,"eighty":-3.972776,"marketCap":43320023},{"date":"2026-04-17","current":-4.424238,"twenty":-8.559934,"median":-5.470931,"eighty":-3.975832,"marketCap":46070501},{"date":"2026-04-24","current":-4.556305,"twenty":-8.47587,"median":-5.457342,"eighty":-3.991112,"marketCap":47445739},{"date":"2026-05-01","current":-4.622339,"twenty":-8.432085,"median":-5.425397,"eighty":-4.003336,"marketCap":48133359},{"date":"2026-05-08","current":-4.358205,"twenty":-8.400446,"median":-5.404384,"eighty":-4.008276,"marketCap":45382881},{"date":"2026-05-15","current":-4.193121,"twenty":-8.362015,"median":-5.374022,"eighty":-4.02921,"marketCap":43663833},{"date":"2026-05-22","current":-4.84537,"twenty":-8.322657,"median":-5.30269,"eighty":-4.033896,"marketCap":44695262},{"date":"2026-05-29","current":-4.770826,"twenty":-8.310018,"median":-5.274207,"eighty":-4.033896,"marketCap":44007642},{"date":"2026-06-05","current":-4.733554,"twenty":-8.296736,"median":-5.255916,"eighty":-4.033896,"marketCap":43663833},{"date":"2026-06-12","current":-4.696282,"twenty":-8.29422,"median":-5.202548,"eighty":-4.033896,"marketCap":43320023},{"date":"2026-06-18","current":-4.659009,"twenty":-8.281581,"median":-5.134413,"eighty":-4.033896,"marketCap":42976213},{"date":"2026-06-26","current":-9.170666,"twenty":-8.334866,"median":-5.202661,"eighty":-4.036778,"marketCap":84593195},{"date":"2026-07-02","current":-9.692574,"twenty":-8.457014,"median":-5.255916,"eighty":-4.050746,"marketCap":89407442},{"date":"2026-07-10","current":-9.468899,"twenty":-8.632566,"median":-5.274207,"eighty":-4.060344,"marketCap":87344194},{"date":"2026-07-17","current":-8.872433,"twenty":-8.780712,"median":-5.325574,"eighty":-4.060975,"marketCap":81842197},{"date":"2026-07-24","current":-8.648758,"twenty":-8.702145,"median":-5.388594,"eighty":-4.061256,"marketCap":79778948},{"date":"2026-07-31","current":-9.319783,"twenty":-8.799568,"median":-5.404384,"eighty":-4.062616,"marketCap":85968695},{"date":"2026-08-07","current":-8.723317,"twenty":-8.809169,"median":-5.425397,"eighty":-4.064456,"marketCap":80466698},{"date":"2026-08-14","current":-7.828617,"twenty":-8.799568,"median":-5.457342,"eighty":-4.064456,"marketCap":72213703},{"date":"2026-08-21","current":-13.226039,"twenty":-8.846984,"median":-5.470931,"eighty":-4.064456,"marketCap":77715700}],"updateTime":1787576107861},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TELO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659198354","title":"Telomir Net Loss Narrows to $1.72 Million in Q2 FY26; Revenue Flat at no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2659198354","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659198354?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:11","pubTimestamp":1786655518,"startTime":"0","endTime":"0","summary":"Telomir net loss narrows to $1.72 million in Q2 FY26; revenue flat at no revenueTelomir Pharmaceuticals posted a net loss of USD 1.72 million for the quarter ended June 30, 2026, narrowing from USD 5.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLbmhLYM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658935058","title":"Telomir Plans Phase 1/2 Trial of Telomir-Zn in Triple-Negative Breast Cancer After Preclinical Publication","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935058","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935058?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:06","pubTimestamp":1786363600,"startTime":"0","endTime":"0","summary":"Telomir plans Phase 1/2 trial of Telomir-Zn in triple-negative breast cancer after preclinical publicationTelomir Pharmaceuticals highlighted a peer-reviewed preclinical publication on Telomir-Zn, pos","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL6Dl5Fz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658936649","title":"Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2658936649","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658936649?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363200,"startTime":"0","endTime":"0","summary":"Iron-Rescue Experiments Confirm Iron-Dependent Mechanism. Tumor Suppressor Gene Reactivation and Anti-Tumor and Anti-Metastatic Activity Across Multiple Models.MIAMI, Aug.  10, 2026  (GLOBE NEWSWIRE) ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3341757/0/en/telomir-announces-peer-reviewed-publication-demonstrating-telomir-zn-suppresses-tumor-growth-in-tnbc-and-prostate-cancer-models.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655833556","title":"Telomir Pharmaceuticals Announces Annual Shareholder Meeting Via Virtual Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2655833556","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655833556?lang=en_us&edition=fundamental","pubTime":"2026-07-29 05:00","pubTimestamp":1785272458,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals announces annual shareholder meeting via virtual webcastTelomir Pharmaceuticals will hold its annual shareholder meeting online on Sept. 11, 2026.Shareholders will vote on elec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL7N3wwV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643649205","title":"Telomir Pharmaceuticals announces publication of data on Telomir-Zn","url":"https://stock-news.laohu8.com/highlight/detail?id=2643649205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643649205?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:34","pubTimestamp":1781526884,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals (TELO) announced the peer-reviewed publication of preclinical data demonstrating restoration of insulin sensitivity and sig...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-announces-publication-of-data-on-telomir-zn-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-announces-publication-of-data-on-telomir-zn-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643038952","title":"Telomir Pharmaceuticals reports Telomir-Zn restores insulin sensitivity in preclinical type 2 diabetes model study","url":"https://stock-news.laohu8.com/highlight/detail?id=2643038952","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643038952?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:01","pubTimestamp":1781524895,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals disclosed peer-reviewed preclinical results showing its Telomir-Zn candidate improved insulin sensitivity in a Type 2 diabetes model.Results have already been published, supporting the company’s broader metal-homeostasis approach across metabolic disease and oncology programs.Findings indicate Telomir-Zn restored key measures of glucose control, reinforcing its potential to address insulin resistance.Update adds scientific support as Telomir-Zn moves toward a Phase 1/2 study under an FDA-cleared IND in triple-negative breast cancer.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL7Y4sGX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642639467","title":"Telomir Names Andriy Mushak as Fractional Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642639467","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642639467?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:07","pubTimestamp":1781006833,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals  said Monday that Andriy Mushak has been named as the company's fractional CFO, effective June 6, succeeding Alan Weichselbaum who has stepped down.Telomir said in a regulatory filing that Weichselbaum's departure was not the result of any disagreement with the company on any matter relating to its operations, policies, or practices.Mushak is a partner at LMAM Consulting Group, which has a consulting agreement with Telomir Pharmaceuticals. The company said he remains employed by LMAM under the terms of the agreement.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642459434","title":"Telomir Pharmaceuticals - Alan Weichselbaum to Step Down as CFO Effective June 6, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642459434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642459434?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:01","pubTimestamp":1780952499,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nFWN42G0Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642143445","title":"Telomir Pharmaceuticals - Appoints Andriy Mushak as Fractional CFO Effective June 6, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642143445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642143445?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:01","pubTimestamp":1780952499,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nFWN42G0Z0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642341144","title":"Telomir Pharmaceuticals names Andriy Mushak fractional CFO, replacing Alan Weichselbaum","url":"https://stock-news.laohu8.com/highlight/detail?id=2642341144","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642341144?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:01","pubTimestamp":1780952486,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals named Andriy Mushak fractional CFO effective June 6, 2026.Mushak is a CPA; partner at LMAM Consulting Group leading SEC reporting, financial statements, technical accounting, and M&A support.He previously spent more than a decade at Baker Tilly US in audit, most recently as a senior manager.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL1QYBGv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636423378","title":"Telomir Pharmaceuticals reports peer-reviewed publication of data on Telomir-Zn","url":"https://stock-news.laohu8.com/highlight/detail?id=2636423378","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636423378?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:16","pubTimestamp":1779279404,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals (TELO) announced the peer-reviewed publication of preclinical data showing that Telomir-Zn produced dose-dependent survival...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-reports-peer-reviewed-publication-of-data-on-telomir-zn-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/telomir-pharmaceuticals-reports-peer-reviewed-publication-of-data-on-telomir-zn-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636844364","title":"Telomir says preclinical Telomir-Zn study shows dose-dependent survival gain in Wilson’s disease model","url":"https://stock-news.laohu8.com/highlight/detail?id=2636844364","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636844364?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:00","pubTimestamp":1779278446,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals disclosed a new peer-reviewed preclinical study on Telomir-Zn in a Wilson’s disease model, with results already published in Advances in Redox Research.The study showed dose-dependent survival gains alongside broad signs of disease improvement, including lower liver copper burden and better liver health signals.The findings add external validation for Telomir-Zn’s biological activity in Wilson’s disease, a potential expansion path alongside its lead triple-negative breast cancer program, which received FDA IND clearance in April 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDLb1sdhg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635174011","title":"Telomir net loss narrows to $990,947 in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635174011","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635174011?lang=en_us&edition=fundamental","pubTime":"2026-05-15 03:10","pubTimestamp":1778785828,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals posted a net loss of USD 990,947 for quarter ended March 31, 2026, narrowing from USD 2.18 million a year earlier.Total operating costs fell to USD 1.04 million from USD 2.19 million, led by general and administrative expense dropping to USD 573,539 from USD 1.85 million.Research and development expense rose to USD 467,797 from USD 336,996, while total other income increased to USD 50,389 from USD 7,954 on higher interest income of USD 51,644.FDA cleared an IND to start a Telomir-Zn trial in advanced or metastatic triple-negative breast cancer; company expects cash to fund operations through first quarter of 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL3vLDS4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632654300","title":"Telomir announces U.S. FDA cleared IND application for Telomir-Zn","url":"https://stock-news.laohu8.com/highlight/detail?id=2632654300","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632654300?lang=en_us&edition=fundamental","pubTime":"2026-04-30 23:55","pubTimestamp":1777564548,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals (TELO) announced that the U.S. Food and Drug Administration, FDA, has cleared the Company’s Investigational New Drug, IND, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/telomir-announces-u-s-fda-cleared-ind-application-for-telomir-zn-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/telomir-announces-u-s-fda-cleared-ind-application-for-telomir-zn-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","TELO","BK4007","BK4585","IND","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631632380","title":"Telomir Pharmaceuticals Inc - Plans to Initiate Phase 1/2 Trial for Telomir-Zn in 1H 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631632380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631632380?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:21","pubTimestamp":1777551695,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41D0LT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631634639","title":"Telomir Pharmaceuticals wins FDA IND clearance for Telomir-Zn in triple-negative breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2631634639","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631634639?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:02","pubTimestamp":1777550520,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals received FDA clearance of an IND for Telomir-Zn in advanced or metastatic triple-negative breast cancer.Clearance supports launch of first-in-human Phase 1/2 trial TELO-001 in 1H 2026.Study plans enrollment of about 76 patients, evaluating oral monotherapy safety, dosing, pharmacokinetics, biomarkers, preliminary efficacy.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL9bFWC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629984225","title":"Telomir Pharmaceuticals Completes TELI Acquisition, Expands Telomir-1 Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2629984225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629984225?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:34","pubTimestamp":1777037645,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals, Inc. ( ($TELO) ) has issued an update. On April 22, 2026, Telomir Pharmaceuticals, Inc. completed its previously approved ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-completes-teli-acquisition-expands-telomir-1-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-completes-teli-acquisition-expands-telomir-1-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629084100","title":"Telomir issues 34,389,710 unregistered shares in TELI acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2629084100","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629084100?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:01","pubTimestamp":1777035676,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals completed acquisition of TELI Pharmaceuticals on April 22, 2026, issuing 34,389,710 restricted common shares in an unregistered transaction.Shares were issued to TELI former shareholders under Securities Act Section 4 exemption, relying on Rule 506.Bayshore Trust contributed USD 1 million at closing as condition to transaction.Commitment agreement gives Bayshore option to invest up to USD 4 million tied to Telomir-1 development milestones.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telomir Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Apr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL83z0b8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624555143","title":"Telomir Pharmaceuticals Regains Nasdaq Listing Rule Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2624555143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624555143?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:30","pubTimestamp":1774992648,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On March 30, 2026, Telomir Pharmaceuticals, Inc. disclosed that it h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-regains-nasdaq-listing-rule-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telomir-pharmaceuticals-regains-nasdaq-listing-rule-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624553074","title":"Telomir submits FDA IND for Telomir-1 in advanced triple-negative breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2624553074","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624553074?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:26","pubTimestamp":1774992413,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals submitted an IND to FDA for Telomir-1  in advanced or metastatic triple-negative breast cancer.IND filing supports planned Phase 1/2 oral monotherapy trial, pending FDA clearance.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL53GmVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}